Project Grant HT94252410637
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$3.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
The U.S. Defense Health Agency awarded a $2,534,532 Project Grant to Rush University Medical Center to evaluate evidence-based options for initial PTSD treatment non-responders. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a comprehensive range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The award has a performance period of September 1,...
The Defense Health Agency awarded a $2,206,031 project grant to Rush University Medical Center to fund the PREVENTING THE DEVELOPMENT OF CHRONIC PAIN: TREATING PTSD AT ACUTE PAIN ONSET program. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will support basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries. Specifically, the grant will fund...
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...
This $2,997,922 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at Florida State University (FSU) to develop rapid, non-invasive brain stimulation treatments for post-traumatic stress disorder (PTSD). The award, which runs from September 30, 2024 to September 29, 2028, will enable FSU's Sponsored Research Administration division to conduct cutting-edge scientific studies to advance...
The Defense Health Agency awarded a $1,546,668 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Rush University Medical Center in Chicago, Illinois. The grant supports a Breakthrough Award Levels 1 and 2 for the Defense Health Program Congressionally Directed Medical Research Programs Breast Cancer Research Program. The 3-year award period runs from July 1, 2024 to June 30, 2027. Rush University Medical Center, also known as Rush-Presbyterian St....
This $4,195,886.00 Project Grant award under the Military Medical Research and Development program (CFDA 12.420), administered by the Defense Health Agency, supports research to reduce dropout and improve outcomes from PTSD therapy. The award to the Regents of the University of Minnesota, Office of Sponsored Projects Administration, will investigate when to switch therapies or stay the course to optimize PTSD treatment. The research aims to transform healthcare for military service members and...
The Department of the Army Medical Command has awarded a $4,208,345.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Minnesota. This 4-year grant, which began on September 30, 2024, will fund a "HYBRID 1 EFFECTIVENESS-IMPLEMENTATION TRIAL OF PARTNER-ASSISTED PROLONGED EXPOSURE FOR PTSD" research project. As a prominent non-profit land-grant research institution, the University of Minnesota will leverage its...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $5,596,529 project grant to the Icahn School of Medicine at Mount Sinai to conduct research on understanding the interactions between gene X and stress across different brain cell types in post-traumatic stress disorder (PTSD). This 4-year grant, awarded on Sep 30, 2023, will fund studies to establish a human induced pluripotent stem cell-based platform for testing the functional impact...
The Defense Health Agency awarded a $6,319,054 Project Grant to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, MA, under the Military Medical Research and Development program (CFDA 12.420). The grant funds research to design microbiome-based therapies to prevent and ameliorate post-traumatic stress disorder (PTSD). The project involves collaboration with sub-awardees including Harvard University, the Forsyth Institute, and McLean Hospital. Key...